Mark Bodenrader

Business address
C/O Cerevel Therapeutics Holdings Inc., 131 Dartmouth Street Suite 502, Boston, MA, 02116
Top holdings (ownership)
CERE
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Mark Bodenrader has filed 11 SEC EDGAR filings since 30 Oct 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 05 Aug 2024 01 Aug 2024 001-39311
4 Open Document Open Filing 4 23 Jan 2024 19 Jan 2024 001-39311
4 Open Document Open Filing 4 21 Dec 2023 19 Dec 2023 001-39311
144 Open Document Open Filing 05 Jun 2023
4 Open Document Open Filing 4 05 Jun 2023 01 Jun 2023 001-39311
4 Open Document Open Filing FORM 4 SUBMISSION 08 Feb 2023 06 Feb 2023 001-39311
4 Open Document Open Filing FORM 4 SUBMISSION 03 Jun 2022 01 Jun 2022 001-39311
4 Open Document Open Filing FORM 4 SUBMISSION 11 Feb 2022 09 Feb 2022 001-39311
4 Open Document Open Filing FORM 4 SUBMISSION 05 Feb 2021 03 Feb 2021 001-39311
4 Open Document Open Filing FORM 4 SUBMISSION 30 Oct 2020 28 Oct 2020 001-39311
3 Open Document Open Filing FORM 3 SUBMISSION 30 Oct 2020 27 Oct 2020 001-39311